China 16051-77-7 Factory

Our growth depends within the innovative equipment, fantastic talents and repeatedly strengthened technology forces for 16051-77-7,CAS NO 16051-77-7,Isosorbide 5-mononitrate, Our experienced specialized workforce will probably be wholeheartedly at your provider. We sincerely welcome you to check out our web-site and organization and mail us your inquiry.
16051-77-7, Our company insists on the principle of "Quality First, Sustainable Development", and takes "Honest Business, Mutual Benefits" as our developable goal. All members sincerely thank all old and new customers' support. We'll keep working hard and offering you the highest-quality goods and service.

Hot Products

  • BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE SODIUM SALT

    BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE SODIUM SALT

    Product Name:BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE SODIUM SALT
    Molecular Formula:C21H29N7NaO17P3
    Molecular Weight:767.41
    CAS Registry Number:1184-16-3
  • BOC-GLYCINE METHYL ESTER

    BOC-GLYCINE METHYL ESTER

    Product Name:BOC-GLYCINE METHYL ESTER
    Molecular Formula:C8H15NO4
    Molecular Weight:189.21
    CAS Registry Number:31954-27-5
  • Tofacitinib Citrate

    Tofacitinib Citrate

    Name:Tofacitinib Citrate
    Molecular Formula:C16H20N6O.C6H8O7
    Molecular Weight:504.50
    CAS NO:540737-29-9
    Usage:Tofacitinib Citrate
  • Fucoxanthin

    Fucoxanthin

    Product Name:Fucoxanthin
    Molecular Formula:C42H58O6
    Molecular Weight;658.91
    CAS Registry Number;3351-86-8
  • 2,5-Difluoronitrobenzene

    2,5-Difluoronitrobenzene

    Product Name:2,5-Difluoronitrobenzene
    Molecular Formula:C6H3F2NO2
    Molecular Weight:159.09
    CAS Registry Number:364-74-9
  • Imatinib mesylate

    Imatinib mesylate

    Product Name:Imatinib mesylate
    Molecular Formula:C30H35N7O4S
    Molecular Weight;589.71
    CAS Registry Number;220127-57-1

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept